Clinical Research Studies
Are you satisfied with the current treatment options for your eye conditions?
We are not!
Until we achieve complete control of symptoms that limit vision and can stop (or at least slow) progressive conditions, we will continue to search for better options in treatments.
When a pharmaceutical or medical device company wants to introduce new advancements to the U.S. market, an official FDA (Food and Drug Administration) clinical trial is required.
Dr. Joseph Tauber has been involved in clinical research for over thirty years. He has been the principal investigator in over 150 Phase II-IV clinical trials (both eyedrop medications & devices) since 1989, when he first arrived in Kansas City.
Dr. Tauber is often selected to collaborate with leaders from the pharmaceutical and medical device industry leaders to design and conduct various stages of clinical studies, which have focused on increasing the effectiveness of Dry Eye Management, Glaucoma, Corneal Transplant Surgery, Inflammatory Eye Diseases, and Blepharitis, and other ocular diseases. In addition, he is frequently invited to consult with industry and to present the results of the studies, to other healthcare providers at national meetings.
Clinical research has become an integral part of our practice over the years. We believe this close association with industry leaders has and will continue to afford us the opportunity to offer the latest advances in treatment and technology and provide the highest quality of eye care to our patients throughout the Kansas City region.
Should you volunteer for one of our clinical trials?
You will certainly help advance our ability to better treat eye diseases, whether for you personally and for other patients Examinations for research studies are at no-cost and often some reimbursement is available to compensate for your time and travel.
Because most studies continue for 3-12 months, and new studies open often, we do not list details of ongoing studies here, but invite patients to speak with us to find out if they might be candidates to participate in a study. Our major areas of research include: dry eyes, meibomian gland dysfunction (evaporative dry eye), inflammatory eye diseases (uveitis), corneal transplantation and infections. We are also involved in studies of new innovative contact lenses. There are generally no charges for the visits in research studies, and reimbursement for patient travel costs is often available through these studies.
Tauber Eye Center is affiliated with many pharmaceutical and device innovators to offer ground-breaking treatments and emerging technology. Our participation in FDA-approved clinical trials allows us to provide qualified patients access to advancements in eyecare not yet available to the general public.